R Blinkhorn

Summary

Affiliation: University of Texas Health Center
Country: USA

Publications

  1. ncbi Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections
    Barbara A Brown-Elliott
    Department of Microbiology, Mycobacteria Nocardia Research Laboratory, The University of Texas Health Science Center, Tyler, TX 75708, USA
    Cornea 31:900-6. 2012
  2. ncbi Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria
    Barbara A Brown-Elliott
    Department of Microbiology, The University of Texas Health Science Center at Tyler, USA
    Clin Microbiol Rev 25:545-82. 2012
  3. ncbi Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey
    Barbara A Brown-Elliott
    University of Texas Health Science Center at Tyler, Tyler, Texas, USA
    J Clin Microbiol 50:670-2. 2012
  4. ncbi Successful treatment of disseminated Mycobacterium chelonae infection with linezolid
    B A Brown-Elliott
    Mycobacteria Nocardia Laboratory and Department of Microbiology, University of Texas Health Center, Tyler, TX 75708, USA
    Clin Infect Dis 33:1433-4. 2001
  5. ncbi Newly described or emerging human species of nontuberculous mycobacteria
    Barbara A Brown-Elliott
    Mycobacteria Nocardia Laboratory, Department of Microbiology, University of Texas Health Center, Tyler, Texas, USA
    Infect Dis Clin North Am 16:187-220. 2002
  6. ncbi Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria
    Barbara A Brown-Elliott
    Department of Microbiology, University of Texas Health Center, Tyler 75708, USA
    Antimicrob Agents Chemother 46:3283-5. 2002
  7. ncbi Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria
    Barbara A Brown-Elliott
    University of Texas Health Center, Department of Microbiology, Tyler, Texas 75708, USA
    Clin Microbiol Rev 15:716-46. 2002
  8. ncbi In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria
    Barbara A Brown-Elliott
    Department of Microbiology, The University of Texas Health Center, Tyler, Texas, USA
    Antimicrob Agents Chemother 47:1736-8. 2003
  9. ncbi Mycobacterium neoaurum and Mycobacterium bacteremicum sp. nov. as causes of mycobacteremia
    Barbara A Brown-Elliott
    The University of Texas Health Science Center at Tyler, Department of Microbiology, 11937 U S Hwy 271, Tyler, TX 75708, USA
    J Clin Microbiol 48:4377-85. 2010

Collaborators

Detail Information

Publications9

  1. ncbi Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections
    Barbara A Brown-Elliott
    Department of Microbiology, Mycobacteria Nocardia Research Laboratory, The University of Texas Health Science Center, Tyler, TX 75708, USA
    Cornea 31:900-6. 2012
    ..To characterize formerly designated atypical or nontuberculous mycobacteria (NTM) associated with eye infections...
  2. ncbi Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria
    Barbara A Brown-Elliott
    Department of Microbiology, The University of Texas Health Science Center at Tyler, USA
    Clin Microbiol Rev 25:545-82. 2012
    ..This article reviews the laboratory, diagnostic, and treatment guidelines together with established and probable drug resistance mechanisms of the nontuberculous mycobacteria...
  3. ncbi Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey
    Barbara A Brown-Elliott
    University of Texas Health Science Center at Tyler, Tyler, Texas, USA
    J Clin Microbiol 50:670-2. 2012
    ....
  4. ncbi Successful treatment of disseminated Mycobacterium chelonae infection with linezolid
    B A Brown-Elliott
    Mycobacteria Nocardia Laboratory and Department of Microbiology, University of Texas Health Center, Tyler, TX 75708, USA
    Clin Infect Dis 33:1433-4. 2001
    ..We describe a 57-year-old man with steroid-dependent myasthenia gravis and progressive ulcerating leg nodules due to clarithromycin-resistant Mycobacterium chelonae. The patient was successfully treated with linezolid...
  5. ncbi Newly described or emerging human species of nontuberculous mycobacteria
    Barbara A Brown-Elliott
    Mycobacteria Nocardia Laboratory, Department of Microbiology, University of Texas Health Center, Tyler, Texas, USA
    Infect Dis Clin North Am 16:187-220. 2002
    ..The clinician must learn about these new pathogens to recognize them clinically and assist the laboratory in their recovery...
  6. ncbi Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria
    Barbara A Brown-Elliott
    Department of Microbiology, University of Texas Health Center, Tyler 75708, USA
    Antimicrob Agents Chemother 46:3283-5. 2002
    ..Gatifloxacin was generally fourfold more active than ciprofloxacin. We recommend that both gatifloxacin and ciprofloxacin be tested routinely against rapidly growing mycobacteria...
  7. ncbi Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria
    Barbara A Brown-Elliott
    University of Texas Health Center, Department of Microbiology, Tyler, Texas 75708, USA
    Clin Microbiol Rev 15:716-46. 2002
    ....
  8. ncbi In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria
    Barbara A Brown-Elliott
    Department of Microbiology, The University of Texas Health Center, Tyler, Texas, USA
    Antimicrob Agents Chemother 47:1736-8. 2003
    ..Linezolid has excellent therapeutic potential against most species of NTM...
  9. ncbi Mycobacterium neoaurum and Mycobacterium bacteremicum sp. nov. as causes of mycobacteremia
    Barbara A Brown-Elliott
    The University of Texas Health Science Center at Tyler, Department of Microbiology, 11937 U S Hwy 271, Tyler, TX 75708, USA
    J Clin Microbiol 48:4377-85. 2010
    ..Sequencing studies are currently required to identify these two species. Strain ATCC 25791 (originally submitted as an example of Mycobacterium aurum) is proposed to be the type strain of M. bacteremicum...